Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2018-08-10 | Forward | 10:1 |
The fund primarily invests at least 80% in domestic and foreign biotech companies engaged in R&D, manufacturing, and distribution, using fundamental analysis, and is non-diversified.

This mutual fund aims for capital appreciation by investing at least 80% of assets in biotech companies, offering investors a diversified, professionally managed way to access the sector's growth potential without buying individual stocks.